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ln order to characterize measles virus (MV} infection in peripheral blood mononuclear cells (PBMCs), RNA was 
isolated from PBMCs after PHA-stimulation for 72 hr of 9 patients with acute measles, 16 patients with subacute 
sclerosing panencephalitis (SSPE), 13 patients with various autoimmune diseases, and 16 healthy control donors. The 
RNA obtained was screened for the presence of MV N (nucleocapsid) gene specific transcripts of either positive or 
negative orientation in a S 1 nuclease protection assay. The sensitivity of this assay allowed us to detect one infected 
cell in 20,000 PBMCs or 0.1 to 0.05 copies of MV-specific RNA per cell. Using single-stranded DNA or RNA probes 
expression of MV genomic RNA of negative polarity could be detected in only one case of acute measles and one 
healthy control donor. Conversely, N-specific transcripts of positive polarity, indicating active transcription, could only 
be detected in patients with acute measles. ln addition, in infected PBMCs andin a persistently MV-infected B cellline 
positive stranded N-specific transcripts containing Ieader usually present at very low frequency have been found in 
relatively increased amounts in comparison with transcripts lacking Ieader. Whereas the ratio of these RNA species 
du ring lytic infection with MV in Vero cells is about 1:50, the ratio found here ranges from 1:3 to 1:10. This altered ratio 
indicates a specific regulation of MV specific transcription in cells of lymphoid origin that has not been found in any 
Other cell system analyzed. © 1991 Academic Press.lnc. 
INTRODUCTION 
Measles virus (MV) is the etiological agent for some 
acute and chronic diseases of man. During the acute 
infection the virus reveals a strong predilection to infect 
cells of lymphoid origin. MV can be isolated from pe-
ripheral blood monocuclear cells (PBMCs} and viral an-
tigens as weil as virus-specific RNA can be detected in 
these cell populations (Gresser et al., 1963; Hwpia et 
al., 1988). ln vitro, MV efficiently infects established 8 
or T cell lines, whereas in PBMCs a "silent infection" 
occurs with the expression of MV antigens and release 
of infectious virus upon mitogen stimulation (Joseph et 
al., 1975; Lucas et al., 1978). ln addition, impairment of 
cell mediated and humoral immune functions in acute 
measles and tissue culture could be observed (for re-
view, see Casali et al., 1989; McChesney and Old-
stone, 1989). 
Based on these Observations studies have been 
carried out in order to characterize MV infection in lym-
phocytes not only in acute measles but also in other 
1 Universitats-Kinderklinik, Josef-Schneider-Str. 2, D-8700 WUrz-
burg, Germany. 
2 Institut fOr Molekularbiologie I der Universitat ZOrich, Eid-
genössische Technische Hochschule, Hönggerberg, CH-8093 
Zorich, Switzerland. 
3 To whom requests for reprints should be addressed. 
703 
MV-associated diseases. ln subacute sclerosing pan-
encephalitis (SSPE) either MV antigens or RNA have 
been detected by some groups in PBMCs of patients 
with this disease in the absence of any major alteration 
of the immune response (Horta-Barbosa, 1 979; Wrosz 
et al., 1979; Fournier et al., 1985, 1988). ln chronic 
active hepatitis, in systemic Iupus erythematosis andin 
glomerulonephritis as weil as in healthy controls un-
confirmed reports describe the presence of MV spe-
cific RNA by dot blot or in situ hybridization in PBMCs 
of these patients suggesting that MV may persist in 
lymphoid cells after acute measles and is not cleared 
by the host defence mechanism (Robertson et al., 
1987; Andjaparidze et al., 1989). 
The possibility that MV may persist in PBMCs is of 
general interest not only in the context of life-long im-
munity against this virus but also in relation to the 
pathogenesis of SSPE and certain autoimmune dis-
eases. Therefore, detailed studies implicating tech-
niques of molecular biology are now needed to deter-
mine the state of MV-Iymphocyte interactions. ln the 
present investigation we analyzed PBMCs from 
healthy adult control donors, patients with acute 
measles, SSPE, and various autoimmune diseases for 
the presence of MV-specific transcripts, applying a liq-
uid hybridization assays by using single-stranded N-
gene specific hybridization probes. By this method we 
could achieve quantifications for the transcription of 
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genomic and subgenomic MV-specific RNAs and addi-
tionally provide some information about transcriptional 
regulation of MV in PBMCs. 
MATERIALSAND METHODS 
Cells and virus 
Vero cells were grown in MEM containing 5% FCS; 
EBV-transformed 8-cells (BLCL) and persistently MV-
LEC-infected BLCL-cells (WE-LEC) were grown in 
RPMI 1640 containing 15% FCS. Peripheral blood 
mononuclear cells (PBMCs) were obtained by Ficoll/ 
Paque separation of heparinized peripheral blood from 
patients with acute measles (9 samples), SSPE (16 
samples), systemic Iupus erythematosis (6 samples), 
various autoimmune diseases (7 samples), healthy 
young adults (16 samples), and newborn nonvacci-
nated individuals (2 samples), and from umbilical cord 
material (2 samples). The diagnoses were documented 
by clinical, serological orelectroencephalographic find-
ings. After isolation, cells were either frozen at -70° or 
used directly as fresh material. Stimulation was per-
formed in RPMI 1640 containing 10% FCS in the pres-
ence of 1 0 ~g/ml PHA for 72 hr. The Edmonston strain 
of measles was passaged and titrated in Vero cells. 
lnfections were performed for 48 hr at an input multi-
plicity of 0.1. 
Patients 
SSPE. Sixteen samples from patients of stages 1-111. 
Serum titers {HHT) of 13 patients were between 
1:1024 and 1 :4096, of 1 patient 1 :512, and of 2 pa-
tients 1 :256. CSF titers ranged from 1 :8 to 1:128. 
Acute measles. Eight samples ot patients at different 
tim es of exanthema with serum titers of 1 :32 in the first 
days of exanthema to 1 :51 2 at late stages {mean titer 
1: 128). 
Healthy controls. Sampies from healthy adult donors 
were derived from an age group of about 24-30 years 
with serum titers ranging from 1 :32 to 1 :256. All of 
them had a history of acute measles. Negative controls 
were derived from two newborn individuals (no detect-
able titer in HHT) and umbilical cord lymphocytes. 
Autoimmune diseases. Sampies were obtained from 
6 patients with SLE, 2 patients with pemphigoides bul-
losa, one patient with pemphigoides vulgaris, one pa-
tient with dermatomyositis, one patient with linear lgA-
dermatosis, one patient with Sjögren syndrome and 
one patient with questionable autoimmune disease. 
Extraction of RNA 
RNA extraction from cultured cells was performedas 
described previously by Iysis in guanidinium thiocya-
nate buffer and subsequent centrifugation through 
CsCI gradients (Schneider-Schaulies et al., 1 989). ln 
general the amounts of total RNA obtained from PHA-expand~d PBMCs were about 10 ~L9 from 107 cells. 
This value corresponds to 1 pg RNNcell, which is 
about 1 0 times less than for Vero cells. 
Plasmid DNAs 
Probes used for hybridization analyses were derived 
from the 3'-end of the genome and contained the 185-
bp Psti/BamHI fragment (nt 0-185) in M 13 or pSP6 
vectors (M 13 mp 9/32 or pSP64MV3S, respectively; 
including linker sequences, the size of the cloned frag-
ment was about 260 bp; for detailed description, see 
also legend to Fig. 1 c) or the 420-bp BamHI/Pstl frag-
ment (pSP65MV3L or pSP64MV3L, respectively; de-
tailed description in Fig. 3b) (nt 185-605). 
S1 nuclease protection analysis 
S 1 nuclease protection assays were performed as 
described previously (Billeter et a/., 1984). Briefly, M 13 
probes were labeled by primer extension in the pres-
ence of [32P]dATP and subsequently gel purified (Sam-
bracket al., 1989). The probes were hybridized to sam-
ples of total RNA in an 80% tormamide containing hy-
bridization buffer in a total volume of 30 JLI at 45° for 16 
hr. Nuclease digestionwas performed in a total volume 
of 300 ~LI 1 x S 1 buffer containing 700 U/ml nuclease 
S 1 (Pharmacia Fine Chemicals) for 45 min at 30°. The 
digestion was followed by deproteinization with pro-
teinase K and subsequent phenol extraction. Following 
precipitation, samples were separated on 80/o se-
quencing gels. The same protocol for the nuclease 
protection assay was used for the labeled transcripts 
derived from the pSp6 vectors (Melton et al., 1984; 
[32P]CTP, 410 Ci/mmol, Amersham-Buchler). The tran-
scription vector used (pSP65MV3L) was linearized by 
Pvull digestion in order to elongate the probe. Quantifi-
cation of the signals was obtained by excising the ap-
propriate bands from the gels followed by scintillation 
counting. Copy numbers were determined by dividing 
the total amount of radioactivity incorporated in spe-
cific bands (following subtraction of the counts corre-
sponding to the background of each lane) divided by 
the number of counts incorporated per molecule of 
probe. The calculation was performed as follows: 0.4 
~-tCi/pmol (specific activity of [32P]CTP) x 2.2 x 106 
(cpm/1 ~-tCi) = 8.8 x 106 cpm/pmol; 8.8 x 105 divided 
by 6 x 1011 (corresponding to 1 pmol of molecules) 
revealed the number of cpm/molecule CTP. This QUO-
tient was multiplied by the number of C-residues con-
tained in the individual probe (for example, the 420-bp 
fragment would contain 105 C-residues. revealing 1.2 
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X 1 o-4 cpm/copy of the probe). The calculated total 
copy numbers were divided by the amount of RNA ap-
plied to the individual hybridization reaction (usually 5 
~g of RNA) and standardized to yield the value of "copy 
number per 1 0 pg RNA." 
Northern blot analysis 
RNA analyses were performed as described 
(Schneider-Schaulies et al., 1989), Northern blots were 
hybridized to the Iabeted M 13 single-stranded DNA at 
48° in 50% formamide for 16 hr and subsequently 
washed in 0.2X SSC, 0.2% SOS at 70°. 
RESULTS 
The sensitivity of the methods applied 
ln order to determine the sensitivity of our detection 
systems, control experiments with Northern blots and 
nuclease 81 protection assays were performed. Syn-
thetic RNA transcripts of the pSP64MV3s N-specific 
clone (Fig. 1 c) were serially diluted with total RNA ex-
tracted from uninfected Vero cells. The mixtures were 
either separated on a formaldehyde containing aga-
rase gel and probed with the Iabeted ssDNA M 13 
clone (mp9/32) containing negative stranded se-
quences corresponding to the 3'-end of the MV ge-
nomes (Fig. 1 c) or subjected to liquid hybridization in a 
nuclease S 1 protection assay. 
Using the Northern blot analysis specific hybridiza-
tion could be detected down to 1 copy/infected cell 
(calculated as 1 0 pg of total RNA for Vero cells) (not 
shown). The nuclease S 1 analysis was at least 1 0 
times as sensitive because specific signals could be 
detected down to 0.1 copy/cell (Fig. 1 a, lane 7). ln lane 
8 (representing 0.01 copy/cell}, a faint specific signal 
could be detected as weil almest at the background 
Ievei (barely visible in the figure). Smaller bands repre-
sent artifacts due to the nuclease digestion. By per-
forming the same analysis using a labelad RNA tran-
script of negative polarity as hybridization probe in a 
nuclease S 1 protection assay, no increased sensitivity 
could be found under our experimental conditions (not 
shown). 
ln a secend set of experiments, persistently MV-LEC 
infected B cells were serially diluted with uninfected B 
cells, RNA was extracted and subjected to nuclease 
81 protection assay using the M13 probe (mp 9/32; 
Fig. 1 c) specific for the plus strand transcripts contain-
ing Ieader and N-gene sequences. Total control RNA 
from Vero cells lytically infected with MV revealed clear 
signals for the protected fragments corresponding to 
the 185-nt leader-containing and 120-nt leader-free N-
gene-specific transcripts at a ratio of about 1 :50 (Fig. 
1 b, lane 3, and Fig. 1 c). Conversely, the ratio between 
leader-containing and leader-free N-specific tran-
scripts in the persistently infected B-cells appeared to 
be altered in favor of the leader-containing sequences 
(ratio about 1 :3; Fig. 1 b, lane 5; Table 1 ). Signals corre-
sponding to the N-specific 120-nt fragment could be 
visualized down to a dilution of one infected cell in 
20,000 (Fig. 1 b, lane 6). The persistently infected B-
cells contain about 2000 copies of the N mRNN1 0 pg 
RNA (representing about 1 0 cells) as determined by 
Northern blots containing synthetic RNAs as internal 
standards, as described elsewhere (Cattaneo et al., 
1987) (not shown). Thus, the detection Iimit of the 
method ranges areund 0.1 copy/1 0 pg RNA or 0.01 
copy/cell. The slightly lower sensitivity is probably due 
to the concurrent hybridization of Iabeiied transcripts 
with viral negative-stranded transcripts present in the 
hybridization reaction containing total RNA from lyti-
cally infected cells. Under our experimental conditions 
the sensitivity of the protection assay was at least 1 0 to 
20 times higher than that of the Northern blot. Forthis 
reason, nuclease protection assays were chosen for 
further experiments. 
Nuclease protection analysis of N-gene specific 
transcripts of positive polarity in PBMCs from 
patients with acute measles, SSPE, or autoimmune 
diseases and healthy control donors 
PHA-stimulated PBMCs from peripheral blood were 
used either after storage by freezing or as freshly ob-
tained material. Total RNAwas prepared from up to 107 
cells/sample (yielding about 10 ~9 total RNA, seealso 
Materials and Methods) and hybridized to the 32P-Ia-
beled M 1 3 ssDNA corresponding to the 3' end se-
quence of the genome (Fig. 1 c). ln RNA samples de-
rived from healthy adult control donors (16 specimen 
were analyzed), no signals specific for leader-contain-
ing or leader-free N-gene sequences of positive Orienta-
tion were detected (representative in Fig. 2, lane 3) 
except in one case of a Iabaratory worker handling MV 
(not shown}, where the expression rates of the N-gene-
specific transcripts reached Ieveis as in patients with 
acute measles. Negative results were also obtained in 
all RNA samples isolated from PBMCs of patients with 
SSPE ( 16 samples) and autoimmune diseases ( 13 sam-
ples) (representative in Fig. 2, lanes 7 and 8). By con-
trast, RNA from PBMCs of patients with acute measles 
revealed signals specific for both leader-containing 
and leader-free N-specific transcripts (Fig. 2, lanes 5 
and 6). lnterestingly, the signals for the leader-contain-
ing RNAs were relatively streng in relation to those for 
the subgenomic transcripts lacking the Ieader se-
quence (Fig. 2, lanes 5 and 6) exactly as previously 
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FIG. 1. Determination of the sensitivity of the methods applied. (a) A RNA transcript complementary to the 3'-end of the genome was 
transcribed from the pSP64MV3s vector (the MV-specific cDNA fragment is shown in (c)), total amount synthesized determined by the incorpora-
tion of trace amounts of [32P]CTP. Serial dilutions with total RNA from uninfected Vero cells were analysed by nuclease S1 protection assay 
using a complementary single-stranded r2P]dATP-Iabelled DNA (M 13 mp 9/32; see (c)) as hybridisation probe: Lane 1, hybridization probe 
undigested; lane 2, probe digested with S 1-nuclease; lane 3, probe hybridized to 1 ~t9 of RNA from lytically infected Vero cells and, lane 4, to 1~t9 
of RNA from uninfected Vero cells; lanes 5-10, diluted synthetic transcript representing 5 copies (lane 5), 1 copy (lane 6), 0.1 copy (lane 7), 0.01 
copy (lane 8), and 0.001 copy {lane 9) per cell (10 pg RNA) in a total amount of 5~t9 RNA. As a marker, end-labelad pBR322/Hpall-digested DNA 
was used (lane 1 0). (b) Lane 1, undigested probe; lane 2, probe hybridized to 5~t9 RNA of uninfected; lane 3, 1 ~t9 RNA of MV-Edm-infected Vero 
cells; lane 4, 5~t9 RNA of uninfected BLCL-cells; lanes 5 and 6, RNA from persistently infected WE-LEC cells diluted with uninfected BLCL-cells 
to a ratio of 1 infected cell in 10,000 (lane 5) or 20,000 (lane 6) in a final amount of 5 ~tg RNA; lane 7, the same markeras in (a). ln (a) and (b) the 
positions of the probe (arrow), the leader-containing (black triangle) and the leader-free subgenomic transcript (open triangle) are indicated. For 
optimal documentation, the X-rays had to be cut and remounted. (c) Localization of the probes used within the MV genome and the protected 
fragments following nuclease digestion. On the top of (c), the 3' end of the MV genome containing a 54-bp-long noncoding Ieader sequence (nt 
0-54, open box) and the first 121 nt of the N-gene coding sequence are indicated (nt 54-185, hatched box). The cDNA clone (M 13 mp 9/32 
clone) used as Iabeted probe encompasses this particular 185-nt-long MV-specific sequence and, additionally, an about 80-nt-long (G)n[r)m 
linker that was introduced during the cloning procedure, tagether revealing a totallength of 260 bp. Due to the labefing procedure, the 260-bp 
clone was further elongated at its 3'-end by about 30 nt (including the sequencing primer, SP) and by 10 nt at its 5'-end by restriction enzyme 
digestion following primer extension to yield a total probe length of 305 nt (see (a) and (b), lane 1 ). The expected protected fragments following 
nucfease digestion are indicated as the 121-nt-long leader-free and the 185-nt-long feader-containing transcript. For the transcription of the 
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observed in the persistently infected 8-cells (Fig. 1 b, 
lane 5) and in cantrast to the lytically infected Vero cells 
(Fig. 2, lane 4; lanes 3 of Figs. 1 a and 1 b). By quantifi-
cation of all signals for the N-specific transcripts de-
tected in RNA from PBMCs, leader-free transcripts 
proved tobe only 3- to 1 0-fold more abundant than the 
leader-containing Counterparts, whereas in lytically in-
fected Vero cells this ratiowas at least 50:1 (Table 1). 
Quantification of the signals obtained revealed that the 
two kinds of transcripts were expressed at variable 
amounts in the individual samples (Table 1 ). For the 
leader-free transcript, expression rates from 0.1 to 40 
copies/pg RNA (representing the average amount of 
total RNA in lymphocytes} were found in PBMCs from 
patients with acute measles. lt should be kept in mind, 
however, that an augmentation of MV specific se-
quences could have occurred as a consequence of the 
preceding PHA-stimulation of the cultures. A correla-
tion between the stage of the disease (indicated as day 
of exanthema d.e.} and the expressionrate of viral tran-
scripts could not be found (T able 1 ). 
Expression of genomic RNA transcripts in PBMCs 
Since N-gene-specific sequences of positive polarity 
are unequivocally detectable only in the RNA samples 
of PBMCs from patients with acute measles we looked 
for the presence of MV-specific genomic RNA se-
quences in samples of total RNA by using a labeled 
RNA probe complementary to a region close ·tO the 3' 
end of the genome (pSP65MV3L} (Fig. 3b). An RNA 
probe was chosen because of the higher stability of 
RNNRNA in comparison to RNNDNA hybrids and the 
possibility to obtain a large quantity of probe able to 
compete out the excess of unlabeled positive stranded 
transcripts. The signal at position 622 in all lanes 
corresponds to the position of the undigested probe 
(Fig. 3, lane 1} that has not been digested completely in 
lanes 2-18. As negative controls, RNA from PBMCs of 
nonvaccinated newborn children and umbilical cord 
lymphocytes were used (Fig. 3, representative in lane 
3). As positive controls for the hybridization, either the 
antisense transcript to the labeled probe (Fig. 3, lane 2} 
or minus pA-RNA from an SSPE brain (Fig. 3, lane 4) 
were analyzed. 
Signals for protected fragments of the expected size 
(420 bp} were clearly detectable in the RNA of PBMCs 
from one patient with acute measles (lane 1 O} and the 
same healthy control donor who had also responded to 
probes of the opposite polarity, a technician in our labo-
ratory working with MV (lane 16). ln all other samples 
tested, very faint signals not clearly discernible from 
background were obtained representing possibly MV 
RNA at a concentration which did not allow us to con-
firm its specificity (representative in lanes 5-9 for the 
SSPE patients, in lanes 11-13 for patients with acute 
measles, in lanes 14 and 1 5 for the healthy control 
donors, and in lanes 17 and 1 8 for patients with au-
toimmune diseases). PBMCs from one patient with 
acute measles were obtained at the first day of rash 
(lane 1 0), and 11 days later (lane 11) when the signal 
intensity markedly dropped to the Ievei of the other 
samples analyzed. The signal observed in lane 18 
(PBMCs from a patient with SLE} did not correspond 
exactly to the electrophoretic mobility expected and 
seen in the other lanes. Therefore it was considered as 
clearly nonspecific. No major differences in signal in-
tensities could be detected except for the two cases 
described above (lane 1 0 and 16}. The obviously 
slightly different electrophoretic mobility of the specific 
signal in lanes 2-9 and lanes 1 0-17 is due to the fact 
that the protected fragments were separated on two 
gels that were mounted tagether for the documenta-
tion. 
By quantification of the signals obtained the 
amounts of MV-specific transcripts within the total cell 
population analyzed could be calculated. Expression 
frequencies were determined at 0.06 copies of gena-
rnie RNA per cell for the healthy control (Fig. 3, lanes 
16) and at 2 copies per cell for the patient with acute 
measles. Since the signals for the majority of all other 
samples tested were at or even beyond our detection 
Iimit (see Figs. 1 a and 1 b} they would contain less than 
0.05-0.01 copies of MV genomic RNA per cell if these 
signals were specific. 
DISCUSSION 
Persistent infections of measles virus of lymphoid 
tissue have been of interest in the context of lifelong 
immunity, in the etiology of autoimmune diseases and 
CNS infections (Fournier et al., 1985, 1988; Robertson 
et al., 1987; Anjaparidze et al., 1989). ln particular, in 
SSPE and MI BE (measles inclusion body encephalitis} 
persistently infected lymphocytes could play an impor-
tant pathogenic role since measles virus could be 
transported by such cells to the CNS and initiate aper-
sistent infection. lf this would occur the great variability 
in the incubation period observed between acute 
synthetic RNA complementary to the probe, the pSP64MV3s cDNA clone was used. ln the multiple cloning site of the pSP64 vector the 
185-nt-long MV-specific sequence (nt 0-185) lacking the 80-nt (G)nmm linker sequences was cloned (Since the Pstl site used for cloning into 
the vector did not correspond to the Pstl site in the original clone 5' to the linker sequence it is indicated as (Psrt*)). Transcription from the SP6 
promoter revealed a transcript covering the 3'-MV-specific sequence in positive orientation complementary to the probe used. 
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TABLE 1 
POSITIVE STRAND N-GENE-SPECIFIC TRANSCRIPTS IN PBMCs OF 
PATIENTS WITH ACUTE MEASLES, SSPE, AUTOIMMUNE DISEASES, 
AND HEALTHY CONTROLS 
Leader-free Leader-containing 
RNA sampfes transcript transcript Ratio 
SSPE (1-16) ND ND 
autoimmune dis. 
(1-13) ND ND 
controls { 1-15) ND ND 
(16) 5c 2c 1:3 
acute measles d.e. 
A+ 1 50c 15c 1:3 
B+ 11 5c ND 
c 3 5c ND 
0 2-3 2c NO 
E 3-4 1c ND 
F 7 10c 3c 1:3 
G* 3 80c 25c 1:3 
H* 2-3 400c 40c 1:10 
I 10 2c ND 
Vero control 20000c 400c 1:50 
Note. Signals for leader-containing and leader-free N specific tran-
scripts obtained in nucfease protection assays as shown in Fig 2. 
were quantified by excising the corresponding gef slices and deter-
mined by scintiflation counting. The copy number of probe contained 
in each individualsignalwas determined on the basis of the radioac-
tivity incorporated per copy of probe. The vafues indicated as "c" 
have been achieved by distributing the cafculated copy numbers of 
probe to 1 0 pg RNA representing the total amount of RNA of one 
Vero cefl and of about 1 0 PBMCs, respectivefy. ND, not detectable; 
+ indicates that the two sampfes analyzed were derived from the 
same patient on different days of exanthema (d.e.); *RNA analysis is 
shown in Fig. 2, lanes 5 and 6, respectively. 
measles and the onset of these CNS diseases could be 
explained more easily. However, our data do not sup-
port this hypothesis. MV-specific sequences were de-
tected only in patients with acute measles and one 
healthy control donor. ln all other RNA samples derived 
from PBMCs of healthy control donors and patients 
with SSPE or autoimmune diseases no unequivocally 
identifiable MV-specific signals were detectable with 
our method. 
ln cantrast to our data Fournier et al. (1985) using in 
situ hybridization found MV-infected PBMCs in healthy 
adults with the frequency of 0.5-5%, in young children 
1 0-1 5%, and in SSPE patients up to 75%. However, on 
the basis of our detection Ievel of one infected cell 
within 20,000 PBMCs, representing a frequency of 
0.005% of infected cells, we could not confirm this 
Observation neither for healthy controls nor for SSPE 
patients. ln addition, we could not detect any differ-
ences using either PBMCs freshly isolated or storedas 
frozen. ln the healthy control donor the expression fre-
quency for genomic RNA of about 0.06 copies per cells 
was determined. Based on data published by us 
previously (Cattaneo et al., 1987) that an MV-infected 
Heia cell contains about 700 copies of genomic RNA, 
our hybridization experiment would suggest that one 
out of 12,000 cells would be infected in this case. ln all 
other samples in which MV RNA could not be detected 
unequivocally, the copy numbers or infection fre-
quency would be even at least three times lower. Simi-
lar negative data were observed by Hyypia and co-
workers (1985) using dot blot hybridization in their at-
tempts to find any MV-specific signals in total RNA 
derived from PBMCs of 16 healthy control donors. ln 
order to rule out the possibility that positive and nega-
tive strand virus specific RNA might be present in al-
mest equimolar amounts and be undetectable in our 
liquid hybridization assay since the Ionger unlabeled 
minus strand might compete out the excess of labeled 
RNA probe, in situ hybridization experiments were per-
formed which did not reveal any convincing hybridiza-
tion signals clearly discernible from background (data 
not shown). Moreover, PCR analysis of our test sam-
ples so far did not yield positive results since amplifica-
tion of cDNA copied from cytoplasmic RNA sequences 
1 2 3 4 5 6 78 
-
180 190 b ... 
120 b I> 
fiG. 2. Positive strand N-gene-specific transcripts RNA derived 
from PBMCs from patients with acute measles, SSPE, and autoim-
mune diseases. Nuclease protection assay with each 5 ll9 of RNA 
derived from PBMCs of patients with SLE (lane 3}, acute measles 
(lanes 5 and 6), and SSPE (lanes 7 and 8). Lanes 1, 2, and 4 repre-
sent controls including undigested M 13-probe (for description see 
Fig. lc) (lane 1), digested with 81-nuclease (lane 2), and hybridized 
to 1 J.l9 of total RNA from lytically infected Vero cells (lane 4). As 
probe, the M 13 mp9/32 ssDNA described in Fig. 1 c was used. Posi-
tions are indicated for the probe (arrow), the 185-nt leader-contain-
ing (black triangle) and the 120-nt leader-free (open triangle) tran-
script. The double band for the 185-nt transcript (lanes 4-6) repre-
sents an artifact of the nuclease digestion. 
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FIG. 3. MV genomic transcripts in RNA samples from PBMCs of patients with SSPE. acute measles, autoimmune diseases, and healthy 
controls. SP6 protection assay using a Iabeted RNA transcript compfementary to nt 185-605 (BamHI/Psrl fragment) of the N-gene-specific 
genomic sequence. For transcription, the vector (pSP65MV3L) was linearized with Pvull in order to efongate the probe by unspecific sequences 
that coufd be digested by S 1 nuclease (see (b)). (a) Hybridization was performed with each 5 "g of total RNA derived from a newborn nonvacci-
nated individual (lane 3), patients with SSPE (lanes 5-9), acute measfes (lanes 1 0-13), and SLE (lanes 17 and 18). As controls, the undigested 
probe (lane 1) was hybridized to 1 00 ng of the complementary pSP64MV3L transcript (lane 2) and to 5 "9 of minus pA-RNA derived from the brain 
of a patient with SSPE (lane 4). The position of the specific signal for the genomic RNA is indicated by a black triangle, and the position of the 
probe is indicated by the arrow. As marker. pBr322/Hpall was used. (b) Locafization and orientation of the MV-specific transcripts used as 
probes or synthetic unlabeled RNA transcripts. At the top, the 3'-end of the MV genome is indicated encompassing the Ieader sequence of 54 nt 
(nt 0-54) and the entire N-gene sequence (nt 54-17 44). A cDNA clone covering a 420-bp-long BamHIIPstl fragment within the N-gene sequence 
was introduced into the pSP64 or pSP65 vector, thereby alfowing to obtain transcripts of either positive (pSP65MV3L) or negative (pSP64MV3L) 
orientation (hatched box). The expected size of the protected fragment corresponds to the length of the MV-specific fragment (420 bp). ln order 
to distinguish signals due to an incomplete digestion of the probe from the expected protected fragments, the pSP65MV3L vector was linearized 
with Pvull prior to transcription thereby elongating the probe by 170 nt complementary to vector sequences 3' to the multiple cloning site 
(stippled box). Additionally, about 30 nt 5' to the MV-specific fragment were introduced by transcription of the multiple cloning site (stippled box). 
The total transcript obtained of about 620 nt in length for the positive orientation is indicated. 
has not yet reached higher sensitivity than the nu-
clease protection assays used here. 
The elevated anti-MV antibody titers occurring in 
some patients with autoimmune diseases has given 
support to the hypothesis that in these disorders few 
circulating lymphocytes may be persistently infected 
with measles virus. ln this context, Robertson and co-
workers (1987) carried out dot blot hybridization with 
oligonucleotides complementary to MV N-gene using 
RNA from PBMCs of different autoimmune diseases. 
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With this technique these authors in centrast to our 
study found some positive signals in patients with 
chronic active hepatitis, Iupus erythematosis, and 
cryptogenic cirrhosis. However, no detailed informa-
tion is given about the sensitivity of the reaction or per-
centage of infected PBMCs which would allow a com-
parison to our data. 
Replication of MV in PBMCs infected in vitro has 
been intensely studied (for review, see McChesney 
and Oldstone, 1989; Casali et al., 1989). Fewer reports 
are available on the presence and replication of MV in 
PBMCs in vivo in patients with acute measles. Al-
though the rescue of infectious virus from the PBMC 
fraction of patients with acute measles has been de-
scribed by several authors (Gresser et al., 1963; 
Osunkoya et al., 1974; Sakaguchi et al., 1986) at-
tempts to demonstrate MV specific proteins or RNA 
revealed conflicting results. Whereas Moench and co-
workers failed to detect MV-specific proteins or RNAs 
by indirect immunofluorescence or in situ hybridization 
respectively (Moench et al., 1988). MV-specific RNA 
could be shown in PBMCs of patients with acute 
measles by nonquantitative dot blot hybridization (Hyy-
pia et al., 1985). Our data support the presence of MV-
specific transcripts in PBMCs of patients with acute 
measles. ln support of the findings of Hyypia and co-
workers the amount of MV-specific RNA detected in 
our experiments also varied between different sam-
ples. Our quantitative analysis, however, may not truly 
reflect the proportion of PBMCs infected in vivo, since 
viral replication and spread will have occurred in vitro 
upon PHA Stimulation (Lucas et al., 1978). Moreover, 
our analysis does not provide information about the 
integrity or functionality of the transcripts detected, 
since by the nuclease protection assays only tran-
scripts of defined lengths depending on the labeled 
probe used for protection are detectable. Since, how-
ever, N mRNA-specific sequences are accumulating to 
detectable Ieveis, active polymerase complex should 
be present although the concentration of the corre-
sponding proteins may be too low to be detected by 
indirect immunofluorescence. 
One striking finding regarding the MV transcription 
pattern in PBMCs of acute measles and persistently 
infected 8 cells was the altered ratio between leader-
containing and leader-free N-specific transcripts com-
pared to the lytic infection in cells of nonlymphoid ori-
gin (Cattaneo et al., 1987). Whereas the leader-free 
N-specific transcript definitely represents mRNA, the 
leader-containing transcript could either represent an-
tigenome or mono- or bicistronic transcripts of the N-
gene (Castaneda and Wong, 1989, 1990). The probe 
used for our analysis does not allow to distinguish be-
tween these possibilities. Since, however, synthesis of 
the leader-containing subgenomic RNA species has 
been shown to be dependent on protein synthesis in 
centrast to the transcription of the leader-free RNA 
they have been interpreted to result from aborted at-
tempts of antigenome transcription. Thereby, the high 
expression of leader-containing transcripts might indi-
cate a switch from "active" transcription of mRNA to 
an increased replication of viral genomic RNA in lym-
phocytes. This phenomenon would provide an interest-
ing example for cell-type-specific transcriptional regula-
tion of MV. An attractive model for the absence of MV 
specific mRNAs in the presence of the genomic RNA 
has been described by Carter (Carter et al., 1984) for 
persistently MV-infected C6/SSPE cells in the pres-
ence of virus neutralizing antiviral antibodies. This phe-
nomenon, termed antibody-induced antigenic modula-
tion which has also been described in lymphocytes 
(Fujinami and Oldstone, 1984) may be one possibility 
to explain our findings in PBMCs isolated from patients 
with acute measles. However, since the altered ratio 
between antigenomic and subgenomic transcripts 
could also be shown in persistently infected 8 cells, 
alternative explanations should be taken into account. 
One possible mechanism would be a decreased stabil-
ity of virus-specific monocistronic transcripts in 
PBMCs. This suggestion would not only account for 
the altered proportion of antigenomic versus subgeno-
mic RNA observed in PBMCs of acute measles, but 
could also explain why mRNA specific sequences 
could not be detected in PBMCs of patients with SSPE 
and autoimmune diseases and healthy controls. 
The failure to detect MV-specific transcripts of either 
positive or negative orientation in part of our samples 
could also result from sequence variants in PBMCs 
leading to mismatches with the probes corresponding 
to the Edmonston strain sequence. The possibly mis-
matched hybrids would be partially digested during the 
nuclease assay. Furthermore, it should be mentioned 
that Wagner and co-workers (1988) found a dsRNA-
specific RNA unwinding activity in extracts prepared 
from human celllines of lymphoid origin. RNA unwind-
ing activity has been proposed tobe involved in hyper-
mutational events of MV M-gene in vivo and in tissue 
culture in cells of neural origin (Cattaneo et al., 1988; 
Wong et al., 1989). Further analysis of MV gene ex-
pression in cells of lymphoid origin in tissue culture 
systems may provide important information on the 
mechanisms supporting MV persistence in those cells. 
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